LATEST UPDATES » Vol 21, No 11, November 2017 – Paediatric Illnesses       » Breakthrough new rice variety announced in Northern China       » Ebola vaccine approved in China       » Study reveals anti-cancer properties of a fungus used in traditional medicine       » Chinese scientists create genetically modified low-fat pigs       » China, Brazil and Russia are riskiest markets for compliance and regulation       » Why are Korean eggs salmonella-free?      
INSIDE INDUSTRY For e-subscribers (PDF)
Vol 21, No 03, March 2017
Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia

SWITZERLAND AND SINGAPORE - Mundipharma and Helsinn Group have expanded their collaboration, signing amendments to licensing and distribution agreements for anti-emetic prophylactic agents ALOXI and AKYNZEO to cover a host of additional markets. Chemotherapy induced nausea and vomiting (CINV) is one of the most common side effects of cancer chemotherapy. The prevention of...

Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare

The Asia Pacific Medical Technology Association (APACMed), the Medical Technology Association of Australia (MTAA) and Mecomed (Medical Technology Association Middle East and North Africa) announced the release of a Consensus Statement on the Future of Medical Device Registries on Feb 6, 2017. Medical device registries enable longitudinal tracking of patient outcomes and device performance serving as a compelling...

Lonza Expands Airway Disease Portfolio with Addition of IPF Airway Cells

Lonza now offers cryopreserved lung fibroblasts isolated from donors diagnosed with Idiopathic Pulmonary Fibrosis (IPF) for use in research into this potentially fatal condition. Normal lung fibroblasts and small airway epithelial cells - from both smokers and non-smokers - are also available, offering a complete solution to facilitate IPF and other airway research. Lonza's ability to provide primary cells...

Boston Scientific Launches Interventional Cardiology Online Education Portal for Physicians

SINGAPORE - Boston Scientific announced on 19th Jan the launch of the EDUCARE Virtual Training Institute (VTI) for interventional cardiology to enable therapy-focused, peer-to-peer learning exchange. The addition augments the company's existing offerings of endoscopy, cardiac rhythm management, urology and neuromodulation through the VTI, a non-commercial e-learning platform for...

Pfizer Presented Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE® (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer

SINGAPORE - Pfizer Inc. announced results from a sub-analysis studying Asian patients from the Phase 3 PALOMA-2 trial of IBRANCE® (palbociclib), in combination with letrozole, as first-line therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+, HER2-) metastatic breast cancer. Results showed the combination of IBRANCE and...

Global Healthcare Systems at Pivotal Point as Technology Offers Solutions to Industry Challenges - The Economist Intelligence Unit

ASIA PACIFIC - Global healthcare will move into the digital age when there is a fundamental shift in how stakeholders collaborate to use technology to solve global healthcare challenges. This is the key finding of a report released on 22 Feb by The Economist Intelligence Unit (The EIU), which explores the digital health landscape and the opportunities for the industry to support healthy living around the world...

Cellectricon and Censo Biotechnologies Introduce a Joint Technology Access Program Utilizing High-Quality Human iPSC-based Discovery Services for CNS and Pain Research

Mölndal, SWEDEN and Cambridge, UK - Cellectricon AB and Censo Biotechnologies Ltd announced the introduction of a joint technology access program for a fully humanized phenotypic screening platform targeting preclinical neuroscience and chronic pain research. The approach combines induced pluripotent stem cell-derived (iPSC-derived) cells, sourced and produced by Censo, with Cellectricon's...

news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
news Novogen becomes Kazia Therapeutics
news Transforming healthcare through innovation: addressing unmet healthcare needs in Asia Pacific
Asia Pacific Biotech News

Lady Ganga: Nilza'S Story
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
Healthcare Focus: LUNGS
Get to Know TCM
Diabetes: The Big Picture
The Piece of Your Mind - Brain Health/Science
Advocacies in Support of Rare Disease Patients
Food Science & Technology
Eye – the Window to your Soul
Infectious Diseases
A change of heart — Cardiovascular diseases
Paediatric Illnesses
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy